| Product Code: ETC9962020 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Celiac Disease Treatment Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Celiac Disease Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Celiac Disease Treatment Market - Industry Life Cycle |
3.4 United States (US) Celiac Disease Treatment Market - Porter's Five Forces |
3.5 United States (US) Celiac Disease Treatment Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 United States (US) Celiac Disease Treatment Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.7 United States (US) Celiac Disease Treatment Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.8 United States (US) Celiac Disease Treatment Market Revenues & Volume Share, By Enzyme Type, 2021 & 2031F |
3.9 United States (US) Celiac Disease Treatment Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 United States (US) Celiac Disease Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and diagnosis of celiac disease in the US |
4.2.2 Rising prevalence of celiac disease in the US population |
4.2.3 Advancements in celiac disease treatment options and research |
4.2.4 Growing demand for gluten-free products and dietary supplements |
4.3 Market Restraints |
4.3.1 Limited availability of FDA-approved treatments for celiac disease |
4.3.2 High cost associated with celiac disease diagnosis and treatment |
4.3.3 Challenges in adherence to a strict gluten-free diet |
4.3.4 Lack of universal screening protocols for celiac disease in the US |
5 United States (US) Celiac Disease Treatment Market Trends |
6 United States (US) Celiac Disease Treatment Market, By Types |
6.1 United States (US) Celiac Disease Treatment Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Celiac Disease Treatment Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 United States (US) Celiac Disease Treatment Market Revenues & Volume, By Vitamins and Dietary Supplements, 2021- 2031F |
6.1.4 United States (US) Celiac Disease Treatment Market Revenues & Volume, By Steroids and Immunosuppressive Drugs, 2021- 2031F |
6.1.5 United States (US) Celiac Disease Treatment Market Revenues & Volume, By Therapeutic Vaccines, 2021- 2031F |
6.2 United States (US) Celiac Disease Treatment Market, By End User |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Celiac Disease Treatment Market Revenues & Volume, By Hospitals and Clinics, 2021- 2031F |
6.2.3 United States (US) Celiac Disease Treatment Market Revenues & Volume, By Clinical Research Organisations, 2021- 2031F |
6.2.4 United States (US) Celiac Disease Treatment Market Revenues & Volume, By Research and Academic Institutes, 2021- 2031F |
6.3 United States (US) Celiac Disease Treatment Market, By Drugs |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Celiac Disease Treatment Market Revenues & Volume, By First Line of Treatment, 2021- 2031F |
6.3.3 United States (US) Celiac Disease Treatment Market Revenues & Volume, By Second Line of Treatment, 2021- 2031F |
6.4 United States (US) Celiac Disease Treatment Market, By Enzyme Type |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Celiac Disease Treatment Market Revenues & Volume, By Distension, 2021- 2031F |
6.4.3 United States (US) Celiac Disease Treatment Market Revenues & Volume, By Diarrhoea, 2021- 2031F |
6.4.4 United States (US) Celiac Disease Treatment Market Revenues & Volume, By Anorexia, 2021- 2031F |
6.4.5 United States (US) Celiac Disease Treatment Market Revenues & Volume, By Bloating, 2021- 2031F |
6.4.6 United States (US) Celiac Disease Treatment Market Revenues & Volume, By Gas, 2021- 2031F |
6.4.7 United States (US) Celiac Disease Treatment Market Revenues & Volume, By Fatigue, 2021- 2031F |
6.5 United States (US) Celiac Disease Treatment Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 United States (US) Celiac Disease Treatment Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 United States (US) Celiac Disease Treatment Market Revenues & Volume, By Research centres, 2021- 2031F |
6.5.4 United States (US) Celiac Disease Treatment Market Revenues & Volume, By Clinics, 2021- 2031F |
6.5.5 United States (US) Celiac Disease Treatment Market Revenues & Volume, By Others, 2021- 2031F |
7 United States (US) Celiac Disease Treatment Market Import-Export Trade Statistics |
7.1 United States (US) Celiac Disease Treatment Market Export to Major Countries |
7.2 United States (US) Celiac Disease Treatment Market Imports from Major Countries |
8 United States (US) Celiac Disease Treatment Market Key Performance Indicators |
8.1 Average time from symptom onset to celiac disease diagnosis in the US |
8.2 Percentage of celiac disease patients adopting a gluten-free diet |
8.3 Number of clinical trials for celiac disease treatments in the US |
8.4 Patient satisfaction with available celiac disease treatment options |
8.5 Percentage of healthcare providers educated on celiac disease management |
9 United States (US) Celiac Disease Treatment Market - Opportunity Assessment |
9.1 United States (US) Celiac Disease Treatment Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 United States (US) Celiac Disease Treatment Market Opportunity Assessment, By End User, 2021 & 2031F |
9.3 United States (US) Celiac Disease Treatment Market Opportunity Assessment, By Drugs, 2021 & 2031F |
9.4 United States (US) Celiac Disease Treatment Market Opportunity Assessment, By Enzyme Type, 2021 & 2031F |
9.5 United States (US) Celiac Disease Treatment Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 United States (US) Celiac Disease Treatment Market - Competitive Landscape |
10.1 United States (US) Celiac Disease Treatment Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Celiac Disease Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here